▶주메뉴 바로가기
▶본문 바로가기
Celltrion announced Tuesday that the company has submitted its application for marketing authorization to the European Medicines Agency for CT-P47, a biosimilar referencing Roche's Actemra. Roche's Actemra (tocilizumab) is approved for a wide range of uses, including rheumatoid arthritis, giant ce...
[KH Explains] Will alternative trading platform shake up Korean stock market?
[Herald Interview] Asia’s first Master of Wine empowers Shinsegae’s wine push
Exports to US reach all-time high, widen gap with China
LG Uplus to build hyper-scale data center in Paju
GS chief visits Microsoft headquarters
Fila chairman named this year’s Van Fleet Award winner